Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
WASHINGTON (Reuters) - U.S. Supreme Court justices on Monday signaled reluctance to issue too broad a ruling about patents on human genes, and some indicated they might seek a compromise distinguishing between types of genetic material.
NEW YORK (Reuters Health) - Doctors should talk about breast cancer-reducing drugs with women and offer tamoxifen or raloxifene to those that have a high risk of cancer and aren't likely to suffer side effects, a government-backed panel said on Monday.
NEW YORK (Reuters Health) - Women with breast cancer who had a few alcoholic drinks per week before their diagnosis were slightly less likely to die from their cancer, according to a study that followed newly-diagnosed patients for 11 years, on average.
A large study looking at a 33-year time span found that young women were the only age group to show an increase in metastatic breast cancer as an initial diagnosis.
NEW YORK (Reuters Health) - Doctors should screen women with a family history of breast or ovarian cancer to see if the cancers might be due to certain mutations - and if so, women should be counseled about their personal risks before getting tested, a government-backed panel said this week.
Young women may not be receiving radiation therapy after lumpectomy as often as would be optimal.
LONDON (Reuters) - New research has nearly doubled the number of genetic variations implicated in breast, prostate and ovarian cancer, offering fresh avenues for screening at-risk patients and, potentially, developing better drugs.
NEW YORK (Reuters Health) - More women may get screened for breast and cervical cancers if they don't have to pay for the tests, according to a new study from Japan.
An analysis of previous clinical trials may help define situations with a higher risk of recurrence for women who have mastectomy without radiation therapy. The findings may help clarify when doctors should recommend radiation.
Almost 60 percent of young women treated for breast cancer had memory loss or other cognitive problems up to 28 months after diagnosis, French researchers found.